MedTech Scaleup
-
Why Most Scale-Stage Problems Are Misdiagnosed
The most important problems inside scale-stage MedTech organisations are often misdiagnosed. What appears to be a hiring issue, communication breakdown or operational slowdown may actually be a sign that organisational complexity has begun outpacing leadership architecture. Recent developments involving Ennov, xWave Technologies and ŌURA illustrate this particularly clearly. These are often presented as growth stories,…
-
When Regulatory Conversations Quietly Rewrite the Strategy
Most MedTech strategies are not rewritten in board meetings. They are rewritten gradually, often almost invisibly, through conversations with regulators that at the time appear to be clarifications rather than decisions. This is not because regulators intend to shape company direction. It happens because evidence-based environments reveal reality step-by-step, and each clarification alters what the…
Harun Rabbani 